Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Regulatory News (SLN)

  • There is currently no data for SLN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding in Company

22 Sep 2017 14:01

RNS Number : 5998R
Silence Therapeutics PLC
22 September 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Silence Therapeutics plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Aviva plc & its subsidiaries

City and country of registered office (if applicable)

London, England

4. Full name of shareholder(s) (if different from 3.)v

Name

Registered Holder:

Chase (GA Group) Nominees Limited 2,651,683*

 

HSBC Global Custody Nominee (UK) Limited 651,949*

State Street Nominees Limited 50,617*

Available on Request 7,076*

*denotes direct interest

 

Chase (GA Group) Nominees Limited 119,537

 

Chase Nominees Limited 55,444

 

Vidacos Nominees Limited 156,300

 

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

20/09/2017

6. Date on which issuer notified (DD/MM/YYYY):

21/09/2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

5.28%

5.28%

69,991,624

Position of previous notification (if

applicable)

6.39%

6.39%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary SharesGB00B9GTXM62

3,361,325

331,281

4.80%

0.48%

SUBTOTAL 8. A

3,692,606

5.28%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Aviva plc

5.28%

5.28%

Aviva Group Holdings Limited

5.28%

5.28%

Aviva Investors Holdings Limited

5.27%

5.27%

Aviva Investors Global Services Limited

5.27%

5.27%

Aviva plc

5.28%

5.28%

Aviva Group Holdings Limited

5.28%

5.28%

Friends Provident

International Limited

10. In case of proxy voting, please identify:

Name of the proxy holder

See Section 4

The number and % of voting rights held

The date until which the voting rights will be held

 

 

 

 

11. Additional informationxvi

This notification is prompted by a 5% to 4% change at Direct Interest Level (Box 8A)

 

Place of completion

Norwich, England

Date of completion

21 September 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPGURABUPMGPP
Date   Source Headline
23rd Jul 20205:02 pmRNSResults of EGM
22nd Jul 20204:29 pmRNSHolding(s) in Company
22nd Jul 20204:24 pmRNSHolding(s) in Company
21st Jul 20207:00 amRNSSilence Therapeutics to Participate in Conferences
16th Jul 20207:00 amRNSMallinckrodt Exercise of Options
2nd Jul 202010:50 amRNSHolding(s) in Company
2nd Jul 20207:00 amRNSCircular and notice of general meeting
30th Jun 202012:39 pmRNSHolding(s) in Company
29th Jun 20204:55 pmRNSHolding(s) in Company
23rd Jun 20207:00 amRNSBusiness Update
23rd Jun 20207:00 amRNSSubmission of Registration Statement to the US SEC
10th Jun 20205:58 pmRNSHolding(s) in Company
10th Jun 20207:00 amRNSResults of AGM
5th Jun 20204:33 pmRNSHolding(s) in Company
1st Jun 20204:19 pmRNSAdditional Listing
29th May 20204:41 pmRNSSecond Price Monitoring Extn
29th May 20204:36 pmRNSPrice Monitoring Extension
29th May 20209:37 amRNSPDMR Shareholding
21st May 20204:28 pmRNSGrant of Share Options
20th May 20207:00 amRNSNASDAQ Intention to List
20th May 20207:00 amRNSBroker Appointment
20th May 20207:00 amRNSCompany Update
14th May 20207:00 amRNSParticipation at RBC Virtual Healthcare Conference
12th May 20204:12 pmRNSHolding(s) in Company
12th May 20209:30 amRNSPDMR Dealing
7th May 20207:00 amRNSNotice of AGM
20th Apr 20203:28 pmRNSAdditional listing – correction
20th Apr 20207:00 amRNSPDMR Dealing and Additional Listing
17th Apr 20209:34 amEQSEdison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN)
16th Apr 20207:00 amRNSSilence Therapeutics publication of Annual Report
14th Apr 20207:00 amRNSFinal results year ended 31 December 2019
9th Apr 20207:00 amRNSSilence Announces COVID-19 Partnership
2nd Apr 20207:00 amRNSPresentation at Conference and Notice of Results
1st Apr 20204:12 pmRNSAdditional Listing
31st Mar 202011:51 amRNSHolding(s) in Company
30th Mar 20203:00 pmRNSHolding(s) in Company
25th Mar 20202:56 pmEQSEdison Investment Research Limited: Edison issues update on Silence Therapeutics (SLN)
25th Mar 20207:01 amRNSR&D Update
25th Mar 20207:00 amRNSCollaboration with AstraZeneca
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:36 pmRNSPrice Monitoring Extension
17th Mar 202012:07 pmRNSSecond Price Monitoring Extn
17th Mar 202012:02 pmRNSPrice Monitoring Extension
13th Mar 202012:07 pmRNSSecond Price Monitoring Extn
13th Mar 202012:02 pmRNSPrice Monitoring Extension
10th Mar 20201:23 pmRNSHolding(s) in Company
2nd Mar 202012:24 pmRNSHolding(s) in Company
19th Feb 20209:14 amRNSHolding(s) in Company
18th Feb 20207:03 amRNSSilence to Present at Cowen Health Care Conference
17th Feb 202010:00 amRNSSilence Launches Scientific Advisory Board

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.